Expiration Date: July 1, 2019
Title: Internal Medicine – Rheumatology: Polymyalgia Rheumatica; Osteoporosis; FAQs
Faculty: William T. Ayoub, M.D., F.A.C.P., F.A.C.R. and John W. Pendleton, M.D., F.A.C.P., F.A.C.R.
Original Release Date: July 1, 2016 Review Date: July 1, 2017 Expiration Date: July 1, 2019
TOPIC 1: Polymyalgia Rheumatica and Giant Cell Arteritis.
Upon completion of this session, the participant should be able to: EBM, COMP
- Integrate and relate the typical symptoms, physical findings, and laboratory abnormalities in polymyalgia rheumatica.
- Use evidence based information to determine the appropriate initial dose of prednisone in patients with PMR.
- Detect the typical and atypical presentations of GCA.
- Determine the appropriate indication and technique for temporal artery biopsy.
- Prescribe the most effective treatment and distinguish the most serious complications of GCA.
TOPIC 2: Osteoporosis: Evaluation and Treatment.
Upon completion of this session, the participant should be able to: GL, EBM, COMP
- Identify patients who are at risk for osteoporosis and should be evaluated with bone density testing as recommended by the International Society of Clinical Densitometry and National Osteoporosis Foundation guidelines.
- Recommend the various nonpharmacologic and pharmacologic treatments for osteoporosis as recommended by the National Osteoporosis Foundation guidelines.
TOPIC 3: The Geriatric Patient: Evidence-Based Answers to Frequently Asked Questions.
Upon completion of this session, the participant should be able to: EBM, COMP
- Apply evidence based recommendations to patients questions about the use of multivitamins.
- Recommend the most appropriate treatment for nocturnal leg cramps.
- Advise the appropriate dietary recommendations for patients with arthritis.
- Recommend evidence based treatment for restless leg syndrome.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.